 |
Julian Hong, M.D., M.S.Assistant Professor
|
Professional Focus
Dr. Julian Hong specializes in the treatment of genitourinary malignancies. He has expertise in modern radiation therapy techniques including intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT).
His informatics research program focuses on the development and implementation of computational tools in the clinic to provide personalized, precision cancer care for patients. His lab combines clinical domain knowledge with data science expertise to generate insights from real world data, develop actionable machine learning tools, and evaluate the benefit of these advances in patient care.
Dr. Hong serves on the NRG national cooperative group Cancer Care Delivery Research (CCDR) Committee. He is also a member of the American Society of Radiation Oncology (ASTRO) Science Education and Program Development Subcommittee and the American Medical Informatics Association (AMIA) Informatics Summit Scientific Program Committee.
Education
| 2004-2008 | Stanford University | BS | Biomedical Computation |
| 2007-2009 | Stanford University | MS | Bioengineering |
| 2010-2014 | University of Wisconsin-Madison | MD | Medicine |
| 2014-2015 | Yale-New Haven Medical Center | Intern | Internal Medicine |
| 2015-2019 | Duke University Medical Center | Resident | Radiation Oncology |
Professional Experience
| 2019- Present | University of California, San Francisco | Assistant Professor | Radiation Oncology |
Awards & Honors
| 2009 | American Association for the Advancement of Science (AAAS)/Science Program for Excellence in Science |
| 2011 | National Student Research Forum Excellence in Radiology Research Award |
| 2012 | Herman and Gwendolyn Shapiro Excellence in Student Research Award |
| 2014 | University of Wisconsin Dylan Cappel Memorial Scholarship in Oncology |
| 2018 | Google Kaggle NCAA March Madness Machine Learning Competition, 3rd Place of 934 |
Recent Significant Publications :
Lafata KJ, Zhou Z, Liu JG, Hong J, Kelsey CR, Yin FF. An Exploratory Radiomics Approach to Quantifying Pulmonary Function in CT Images. Sci Rep. 2019 Aug 8;9(1):11509. doi: 10.1038/s41598-019-48023-5. PMID: 31395937.
Spiegel DY, Hong JC, Oyekunle T, Waters L, Lee WR, Salama JK, Koontz BF. A nomogram for testosterone recovery following combined androgen deprivation and radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):834-842. doi: 10.1016/j.ijrobp.2018.11.007. PMID: 30419308.
Hong JC, Boyer MJ, Spiegel DY, Williams CD, Tong BC, Shofer SL, Moravan MJ, Kelley MJ, Salama JK. Increasing PET Use in Small Cell Lung Cancer – Survival Improvement and Stage Migration in the VA Central Cancer Registry. J Natl Compr Canc Netw. 2019 Feb;17(2):127-139. doi: 10.6004/jnccn.2018.7090. PMID: 30787126.
Lafata K, Hong JC, Geng R, Ackerson B, Liu JG, Zhou Z, Torok J, Kelsey C, Yin FF. Associations of Pre-treatment Radiomic Features with Local Lung Cancer Recurrence Following Stereotactic Body Radiation Therapy. Phys Med Biol. 2019 Jan 8;64(2):025007. doi: 10.1088/1361-6560/aaf5a5. PMID: 30524018.
Hong JC, Niedzwiecki D, Palta M, Tenenbaum JD. Predicting toxicity in radiation and chemoradiation: An internally validated pre-treatment machine learning algorithm for emergency visits and hospital admissions. JCO Clin Cancer Inform. 2018 Dec;(2):1-11. doi: 10.1200/CCI.18.00037. PMID: 30652595.
Hong JC, Cui Y, Patel BN, Rushing CN, Faught A, Eng J, Higgins K, Yin FF, Das S, Czito BG, Willett CG, Palta M. Association of interim FDG-PET imaging during chemoradiation for squamous anal canal carcinoma with recurrence. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1046-1051. doi: 10.1016/j.ijrobp.2018.04.062. PMID: 29891206.
Lafata K, Cai J, Wang C, Hong J, Kelsey C, Yin FF. Spatial-Temporal Variability of Radiomic Features and its Effect on the Classification of Lung Cancer Histology. Phys Med Biol. 2018 Nov 8;63(22):225003. doi: 10.1088/1361-6560/aae56a. PMID: 30272571.
Hong JC, Spiegel DY, Havrilesky LJ, Chino JP. High Volume Providers and Brachytherapy Practice: A Medicare Provider Utilization and Payment Analysis. Brachytherapy. 2018 Nov - Dec;17(6):906-911. doi: 10.1016/j.brachy.2018.07.007. PMID: 30057292.
Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK. Classification for Long-term Survival in Oligometastatic Patients treated with Ablative Radiotherapy: A Multi-institutional Pooled Analysis. PLoS One. 2018 Apr 12; 13(4): e0195149. doi: 10.1371/journal.pone.0195149. PMID: 29649281.
Hong JC, Foote J, Broadwater G, Sosa JA, Gaillard S, Havrilesky LJ, Chino JP. Data-derived treatment duration goal for cervical cancer: Should 8 weeks remain the goal in the era of concurrent chemoradiation? JCO Clin Cancer Inform. 2017 Nov;1:1-15. doi: 10.1200/CCI.16.00072. PMID: 30657372